baber/WOPTO huggingface dataset:
Patent NZ-220779-A (NZ)
Title: 4-(aroylamino) piperidine butanamides, intermediates, and compositions
Inventor: VAN DAELE G H P
IPC: C07D401/12
Filed: 1987-06-19
Abstract: The use for the manufacture of a medicament for the treatment of diarrhea of a compound of formula <CHEM> wherein Ar is thienyl, halothienyl, furanyl, halofuranyl, pyridinyl, aminopyridinyl, thiazolyl, imidazolyl or a radical of formula <CHEM> Ar<1> and Ar<2> are, each independently, phenyl or halophenyl; the pharmaceutically acceptable acid addition salts and possible stereochemically isomeric forms thereof; pharmaceutical compositions containing such compounds as an active ingredient and methods of preparing said compounds and pharmaceutical compositions; novel compounds of formula (I).
Patent NZ-221829-A (NZ)
Title: Composition for enhancing remineralisation of teeth
Inventor: HAMMARSTROM LARS
IPC: A61K35/32
Filed: 1987-09-16
Abstract: A composition for use in inducing binding between parts of living mineralized tissue by regeneration of mineralized tissue on at least one of the parts, characterized in that it contains as an active constituent a precursor to dental enamel, so called enamel matrix; process for inducing binding between parts of mineralized tissue using such composition.
Patent NZ-225411-A (NZ)
Title: Hgm-csf human granulocyte macrophage colony stimulating factor and vector for its expression containing the sr#a# promoter of the plasmid deposited in atcc67318
Inventor: TAKASHI YOKOTA
IPC: C12R1/19
Filed: 1988-07-14
Abstract: Human granulocyte-macrophage colony stimulating factor (GM-CSF) polypeptides are provided, as well as methods for synthesizing conformationally and antigenically neutral muteins. The disclosed GM-CSFs promote growth and development of various hematopoietic lineages, and may be useful in treating conditions involving depressed blood cell populations and/or depressed blood cell regeneration, such as myeloid hypoplasia, chronic infections, and hematopoiesis after bone marrow transplantation. The invention also includes a novel mammalian expression vector.
Patent NZ-225447-A (NZ)
Title: Piperazinyl derivatives of purine and purine isosteres and pharmaceutical compositions
Inventor: MACCOSS MALCOLM
IPC: C07D473/34
Filed: 1988-07-18
Abstract: There are disclosed certain 6-piperazino-purine and heteroaromatic derivatives thereof which have oral hypoglycemic activity and with such ability to lower blood sugar are useful in the treatment of type II diabetes and/or obesity with associated insulin resistance. Processes for the preparation of such compounds and compositions containing such compounds as the active ingredient thereof are also disclosed.
Patent NZ-228392-A (NZ)
Title: Therapeutically useful tetralin derivatives
Inventor: ANDERSSON BENGT RONNY
IPC: C07C321/24
Filed: 1989-03-20
Abstract: This invention is therapeutically useful tetralins and pharmaceutically acceptable acid addition salts thereof of the formula <CHEM> wherein -YR1 is one substituent on the 5, 6, 7 or 8 position of the aromatic ring, and is -S(C1-C3)alkyl or OR1 wherein R1 is selected from the group consisting of (C1-C8) alkyl, (C1-C8) alkenyl,- CH2-(C3-C8) cycloalkyl or benzyl;  wherein R2 is hydrogen or (C1-C3) alkyl;  wherein R3 is -CH2-(C3-C8) cycloalkyl; wherein R4 is hydrogen, (C1-C8) alkyl, -CH2-(C3-C4) cycloalkyl -(CH2)m-R5 or -CH2-CH2-X-(CH2)nCH3;  wherein n is zero to 3 and m is 2 or 3;  wherein X is oxygen or sulfur; and wherein R5 is phenyl; phenyl substituted with one or two substituent groups selected from chlorine, bromine, fluorine, (C1-C3)alkoxy or (C1-C3)alkyl; 2-thiophene; or 3-thiophene; with the proviso that when R3 contains more than four carbon atoms and R4 is alkyl said alkyl contains from one to 3 carbon atoms.
Patent NZ-228955-A (NZ)
Title: Yeast strains lacking carboxypeptidase ysc alpha activity useful in the production of heterologous protein including desulphatohirudin homologues
Inventor: TRIECHLER HANSJORG
IPC: C12R1/865
Filed: 1989-05-02
Abstract: A novel process for the production of heterologous proteins including the use of certain transformed protease deficient yeast strains is provided. The invention concerns also said transformed yeast strains and methods for the production thereof.
Patent NZ-237710-A (NZ)
Title: Composition comprising amoxycillin hydrate and an effervescent couple containing sufficient excess alkaline component to provide a clear solution
Inventor: MERRIFIELD DAVID ROY
IPC: A61K9/46
Filed: 1991-04-05
Abstract: A pharmaceutical formulation comprising an amoxycillin hydrate and an effervescent couple, for example citric acid plus sodium bicarbonate or sodium glycine carbonate, or tartaric acid or malic plus sodium carbonate. Potassium equivalents of these sodium salts may be used. The formulations may be free flowing powders or granules, or tablets.
Patent NZ-256459-A (NZ)
Title: Interlocking sheet pieces typically for multipack of bottles: tongue on one piece interlocks with flap on other piece
Inventor: NEGELEN EMANUEL
IPC: B65D71/00
Filed: 1993-10-04
Abstract: PCT No. PCT/GB93/02060 Sec. 371 Date May 10, 1995 Sec. 102(e) Date May 10, 1995 PCT Filed Oct. 4, 1993 PCT Pub. No. WO94/07759 PCT Pub. Date Apr. 14, 1994There is provided an interlocking arrangement for coupling two pieces 10, 11 of paperboard. Projecting portions 17 on one piece 10 and openings on the other piece 11 engage as the pieces are urged together. Parallel sided flaps 20 hinged to said one piece 10 and tongues 24 on said other piece 11 are provided on the pieces with said tongues 24 being pushed past the flaps 20 when the pieces are moved together. The free ends of the tongues 24 are bent back slightly and the flaps 20 engage below the bent back ends.
Patent NZ-274539-A (NZ)
Title: Chocolate manufacture with reduced fat and calorie content
Inventor: ZUMBE ALBERT
IPC: A23G1/04
Filed: 1994-10-17
Abstract: PCT No. PCT/GB94/02265 Sec. 371 Date Jul. 9, 1996 Sec. 102(e) Date Jul. 9, 1996 PCT Filed Oct. 17, 1994 PCT Pub. No. WO95/10946 PCT Pub. Date Apr. 27, 1995A process is provided for producing a chocolate composition reduced in fat and calories, which either contains sugar or is free of added sugar, and which has the taste and mouthfeel of traditional chocolate. The process involves developing the chocolate flavour during a normal chocolate-making procedure up to and including conching, and then removing some of the fat, e.g. by means of a cocoa liquor press.
Patent NZ-277498-A (NZ)
Title: Rapamycin derivatives
Inventor: COTTENS SYLVAIN
IPC: C07F7/18
Filed: 1994-12-16
Abstract: PCT No. PCT/EP94/04191 Sec. 371 Date Jun. 14, 1996 Sec. 102(e) Date Jun. 14, 1996 PCT Filed Dec. 16, 1994 PCT Pub. No. WO95/16691 PCT Pub. Date Jun. 22, 1995Novel demethoxy derivatives of rapamycin are found to have pharmaceutical utility, particularly as an immunosuppressants.
Patent NZ-299177-A (NZ)
Title: Audio volume controlled by acceptability of block coded speech
Inventor: PALUMBO NICOLAS
IPC: H04M1/00
Filed: 1996-08-14
Abstract: The control device includes a coded block receiver which examines incoming blocks of digital words and estimates whether the input level is acceptable or not acceptable. If the level is not acceptable, the output volume is reduced. A detection circuit (10) detects when the signal level received is satisfactory following discontinuous transmission, and activates a command (11) to re-establish a sound volume when the detection level is received.
Patent NZ-308398-A (NZ)
Title: 2-amino benzoxazin-4-one derivatives and medicaments
Inventor: ABOOD NORMAN
IPC: C07D413/12
Filed: 1996-05-23
Abstract: A class of compounds for the treatment of viral infections. Compounds of particular interest are defined by Formula I wherein R-R<4 >are as defined herein, or a pharmaceutically-acceptable salt thereof.
Patent NZ-308585-A (NZ)
Title: Impact absorbing macdam containing aggregrate amd bitumen and rubber for use on roads and sports surfaces
Inventor: SPENDLOVE PETER DAVID
IPC: C08L21/00
Filed: 1996-05-23
Abstract: The present invention relates to an impact absorbing macadam comprises 10 to 75 % (preferably 25 to 45 %) of a particulate rubber having a particle size of up to 40 mm, 25 to 90 % (preferably 45 to 65 %) of an aggregate having a particle of up to 40 mm and from 5 to 9 % of a polymer modified bituminous binder. Typically such a macadam has a void volume, interconnected or unconnected, of from 5 to 25 %. The polymer which modifies the bituminous binder is preferably an unbranched styrene butadiene styrene block copolymer forming about 7 % of the modified binder. The macadam is suitable as a base for sports pitches and athletic tracks without a rubber shock pad overlay.
Patent NZ-310969-A (NZ)
Title: Producing an electrical switch by providing a sheet, removing portions, attaching a housing, installing switching and separating portions
Inventor: ENOCH CLAUS
IPC: H01H11/00
Filed: 1996-06-12
Abstract: An electrical switch wherein material is cut out of a sheet or web (1) of electrically conductive material such that a plurality of sets of terminals (5, 6, 7) are formed integrally with the sheet (1). A housing is moulded onto each set of terminals such that the inner terminals (7) are within the housing. Operative elements are mounted in the housing. The individual switches are separated from the sheet (1) either by severing the terminals 5 at 15 and 25 and the terminals 6 at 16, thereby forming a switch with a short distance (e.g. 4 mm) between the terminal ends of terminals (16), or by severing the terminals 6 at 16 and 26 and the terminals 5 at 15, thereby forming a switch with a longer distance (e.g. 6 mm) between the terminal ends of terminal (15). Thus, the switch has a set of at least two metallic terminals (5, 6), each of which comprises at least two sub-sets, wherein each sub-set corresponds to a different application of the switch. <IMAGE>
Patent NZ-314010-A (NZ)
Title: A method of targeting intracellular binding proteins using a lipidized antibody
Inventor: MALFROY-CAMINE BERNARD
IPC: A61K38/19
Filed: 1996-12-23
Abstract: The use of a lipidized antibody which binds specifically with an intracellular protein to target the intracellular protein for binding with a lipidized cellular antibody.  Preferably, the lipidized antibody is glycyldioctadecylamide and is linked to a carbohydrate side chain of an immunoglobulin.
Patent NZ-333979-A (NZ)
Title: Antiparasitic and insecticidal agents isolated during the fermentation of Nodulisporium
Inventor: BYRNE KEVIN M
IPC: C07D209/70
Filed: 1997-08-26
Abstract: The formulae above are examples of compounds isolated from the fermentation of producing cultures of Nodulisporium sp.  These compounds are useful for the treatment of parasitic infection of domestic animals and poultry, particularly ticks, lice, fleas and other biting insects.  They may also be used in the treatment or prevention of parasitic diseases, such as helminthiasis, in humans. Specific strains of the microorganism are MF5954, MF6047, MF6087, MF6206 and MF6222 (ATCC 74245, ATCC 74380, ATCC 74381 and ATCC 74382 respectively.)
Patent NZ-334256-A (NZ)
Title: 1-substituted sulphonyl-pyrrolidine derivatives useful as metalloprotease inhibitors
Inventor: DE BISWANATH
IPC: C07D211/60
Filed: 1997-08-22
Abstract: The 1-substituted sulphonyl-pyrrolidine derivative, an optical isomer, diastereomer or enantiomer thereof or a pharmaceutically-acceptable salt, biohydrolyzable amide, ester, or imide thereof has the formula I wherein: A is alkyl, heteroalkyl, aryl or heteroaryl, substituted or unsubstituted; R1 is OH, alkoxy, NHOR2; R2 is hydrogen or alkyl; W is independently one or more of hydrogen or alkyl or an alkylene bridge that forms a ring; Y is independently one or more of hydroxy, SR3, SOR4, SO2R8, alkoxy, NR6R7; R6 and R7 are independently hydrogen, alkyl, heteroalkyl, heteroaryl, aryl, OR3, SO2R8, COR9, CSR10, PO(R11)2; each R3 is independently hydrogen, alkyl, aryl or  heteroaryl; each R4 is independently alkyl, aryl or  heteroaryl; each R8 is independently alkyl, aryl, heteroaryl, heteroalkyl, amino, alkylamino, dialkylamino, arylamino, diarylamino or alkylarylamino; each R9 is independently hydrogen, alkoxy, aryloxy, heteroaryloxy, alkyl, aryl, heteroaryl, heteroalkyl, amino, alkylamino, dialkylamino, arylamino or  alkylarylamino; each R10 is independently alkyl, aryl, heteroaryl, heteroalkyl, amino, alkylamino, dialkylamino, arylamino, diarylamino or alkylarylamino; each R11 is independently alkyl, aryl, heteroaryl or heteroalkyl; Z is hydrogen, hydroxy, alkyl, alkylene or heteroalkylene and n is 1-3; provided that when A is unsubstituted phenyl or 4-methylphenyl, R1 is NHOR2.  A pharmaceutical composition thereof is useful for preventing or treating a disease associated with unwanted metalloprotease activity in a mammal.
Patent NZ-335162-A (NZ)
Title: Apo b-secretion/mtp inhibitory amides
Inventor: CHANG GEORGE
IPC: A61K31/47
Filed: 1997-11-03
Abstract: his application is directed to compounds of formula (I) or the stereoisomers, pharmaceutically acceptable salts and hydrates thereof.  The compounds are Apo B/MTP inhibitors and are useful in the treatment of various disorders and conditions such as atherosclerosis, pancreatitis, obesity, hypercholesteremia, hypertriglyceridemia, hyperlipidemia, and diabetes.  The compounds are also useful in combination with other pharmaceutical agents including cholesterol biosynthesis inhibitors and cholesterol absorption inhibitors, especially HMG-CoA reductase inhibitors and HMG-CoA synthase inhibitors; HMG-CoA reductase gene expression inhibitors; CETP inhibitors; bile acid sequestrants; fibrates; cholesterol absorption inhibitors; ACAT inhibitors, squalene synthetase inhibitors, ion-exchange resins, anti-oxidants and niacin. This application is also directed to intermediates and processes useful in the preparation of compounds of formula (I).
Patent NZ-336664-A (NZ)
Title: Process for preparing fiber boards where wood particles are mixed with and bonded to an adhesive binder
Inventor: VIIKARI LIISA
IPC: D21F1/66
Filed: 1998-01-14
Abstract: process for manufacturing fiber boards and similar wood-based products from a lignocellulosic raw material having a moisture content of at least 10 wt.%. According to the process, an aqueous fraction is separated from the fibres of the raw material, which fraction later is recycled to the process in order to form at least a part of the agent used for binding the fibres. Before mixing with the fibres, the aqueous effluent is concentrated and enzymatically oxidized in the presence of oxygen in order to polymerize the solubilized wood material and in order to increase its concentration. Lignin can be added to the water solubilized wood material or the solubilized wood material can be added to the fibres together with another binder. Eventually, the mixture is formed into a board and hardened.
Patent NZ-500746-A (NZ)
Title: Lighting circuit, lighting system method and apparatus, socket assembly, lamp insulator assembly and components thereof
Inventor: RICHARDSON RICHARD J
IPC: H01R33/05
Filed: 1998-04-21
Abstract: A lighting system and components are described for a lighting assembly (36), including a socket (44) having a socket body and an electrical connector with a seal in the socket to seal around a light source. The socket is preferably configured to be independent of the mounting arrangement for the lighting assembly. An insulator (90) is also disclosed for a lamp (42) such as a fluorescent lamp having a body which protects the contact (54) on the lamp so as to form a recessed lamp conductor. The combination of a socket and lamp insulator is also disclosed for providing a socket and insulator assembly for reducing the possibility of injury or damage due to high open circuit voltage, environmental effects and the like. Additionally, a lighting assembly is disclosed incorporating the insulator, socket and mounting arrangements.
Patent NZ-505281-A (NZ)
Title: Process for processing sucrose into glucose using 2 fructosyltransferases
Inventor: CATANI STEVEN J
IPC: C12P19/04
Filed: 1999-02-05
Abstract: A process and an apparatus for preparing commercial quantities of glucose from sucrose is disclosed. Sucrose is fed in through an inlet to a reactor vessel where it is contacted with 2 enzymes, a b-2,1-fructosyltransferase and a b-2,6-fructosyltransferase. The glucose is isolated and removed via an outlet. A branched fructan can also be produced and may be isolated and removed via another outlet.
Patent NZ-505543-A (NZ)
Title: N-[cis-2-(6-halo, 2-hydroxy, 3-propionylphenyl)-cyclopropyl]-N'-pyrid-2-yl-urea derivatives and salts, prodrugs, pharmaceuticals thereof; useful for the treatment or prophylaxis of HIV
Inventor: SAHLBERG CHRISTER
IPC: C07D213/85
Filed: 1999-01-15
Abstract: A compound of formula I, wherein: RX is cyano or bromo; R1 is halogen; and R2 is alkyl. Also described is a pharmaceutical composition comprising the compound of formula I and a pharmaceutically acceptable carrier or diluent. The compound of formula I is useful for the treatment or prophylaxis of HIV.
Patent NZ-506593-A (NZ)
Title: Bronze privacy glass
Inventor: KRUMWIEDE JOHN F
IPC: C03C4/08
Filed: 1999-03-15
Abstract: The present invention provides a bronze coloured, infrared and ultraviolet absorbing glass composition having a luminous transmittance of up to 60 percent. The glass uses a standard soda-lime-silica glass base composition and additionally iron and selenium, and optionally cobalt, as infrared and ultraviolet radiation absorbing materials and colorants. The glass of the present invention has a luminous transmittance (LTA) of up to 60 percent and its colour is characterized by a dominant wavelength in the range of 560 to 590 nanometers and an excitation purity of 12 to 75 % at a thickness of 0.160 inches (4.06 mm). In one embodiment of the invention, the glass composition of a bronze coloured, infrared and ultraviolet radiation absorbing soda-lime-silica glass article includes a solar radiation absorbing and colorant portion consisting essentially of 0.7 to 2.2 percent by weight total iron, 0.15 to 0.5 percent by weight FeO, 3 to 100 PPM Se, and optionally up to 200 PPM CoO, and preferably 1.1 to 1.4 percent by weight total iron, 0.24 to 0.36 percent by weight FeO, 20 to 45 PPM Se, and 0 to 70 PPM CoO.
Patent NZ-507143-A (NZ)
Title: Benzamide derivatives for the treatment of diseases mediated by cytokines
Inventor: BROWN DEARG SUTHERLAND
IPC: C07C235/56
Filed: 1999-05-11
Abstract: A compound of formula (I), wherein: R1 and R2, are independently selected from hydroxy, C1-6alkoxy, mercapto, C1-6alkylthio, amino, C1-6alkylamino, di-(C1-6alkyl)amino, carboxy, C1-6alkoxycarbonyl, carbamoyl, C1-6alkylcarbamoyl, di-C1-6alkylcarbamoyl, C1-6alkylsulphinyl, C1-6alkylsulphonyl, arylsulphinyl, arylsulphonyl, C1-6alkylaminosulphonyl, di-(C1-6alkyl)aminosulphonyl, nitro, cyano, cyanoC1-6alkyl, hydroxyC1-6alkyl, aminoC1-6alkyl, C1-6alkanoylamino, C1-6alkoxycarbonylamino, C1-6alkanoyl, C1-6alkanoyloxy, C1-6alkyl, C2-6alkenyl, C2-6alkynyl, halo, trifluoromethyl, aryl, arylC1-6alkyl, arylC1-6alkoxy, heteroaryl, heteroarylC1-6alkyl, heterocyclyl and heterocyclylC1-6alkyl, m and p are independently 0-3 R3 is halo, cyano or C1-6alkoxy, Q is 0-4 and R4 is aryl or cycloalkyl wherein R4 is optionally substituted with up to 3 substituents having any value defined for each R1 group. The compounds are used in the manufacture of medicaments for treating disorders mediated by cytokines.
Patent NZ-508408-A (NZ)
Title: A irus-like particles or gene delivery vehicle provided with a ligand with affinity for a cationic amino acid transporter (hCAT1)
Inventor: VAN ES HELMUTH
IPC: C12N15/87
Filed: 1999-05-20
Abstract: Described is the targeted delivery of substances to cells by a virus-like particle or gene delivery vehicle provided with a ligand capable of binding to a human amino acid transporter.  Provided are, for example, ligands that can bind to the human transporter of cationic L-amino acids (hCAT1).  Such hCAT1 binding molecules find applications in the design of vector systems for entry into human or primate cells.  Preferred are retroviral envelope molecules, which when incorporated in a virus particle, can infect hCAT1 positive cells at high frequencies.  Also described are methods for the design of such hCAT1 binding molecules.
Patent NZ-512381-A (NZ)
Title: Chitosan metal complexes and method controlling microbial growth on plants using same
Inventor: BEN-SHALOM NOACH
IPC: A01N59/20
Filed: 1999-11-24
Abstract: An agricultural formulation includes a chitosan metal complex used for the delivery of metal ions to plants comprises a chitosan chelating polymer and at lest two different metal ions chelated to the chitosan chelating polymer wherein the chitosan metal complex is water soluble. A chitosan metal complex where the metal is a transition metal such as copper, aluminum, manganese or zinc is used to control microbial diseased in plants.
Patent NZ-517953-A (NZ)
Title: Acidic light duty liquid cleaning compositions
Inventor: TOUSSAINT CHRISTINE
IPC: C11D1/72
Filed: 2000-09-28
Abstract: A light duty liquid detergent composition comprising: alkali metal salt of an anionic sulfonate surfactant, ammonium or alkali metal alt of an ethoxylated alkyl ether sulfate, an ethoxylated non-ionic surfactant, polyethylene glycol, an organic acid, a solubilizing agent, a cosurfactant, an inorganic magnesium salt, a water insoluble saturated organic diester, terpene or essential oil, a thickener, and the balance being water.
Patent NZ-519494-A (NZ)
Title: Method and apparatus for managing maintenance operations
Inventor: BUDNICK DANIEL J
IPC: G06Q10/00
Filed: 2002-06-11
Abstract: A computerized method of assisting the routing of a part comprises providing at least one computer; receiving part identifier information at the computer; and generating a tag for affixing to the part. The tag has information thereon responsive to the part identifier information wherein the part is routed according to the information on the tag. A computerized method of assisting the handling of a part comprises providing at least one computer; receiving part identifier information at the computer; processing the part identifier information at the computer; and generating output from the computer responsive to the part identifier information wherein the part is handled according to the output. A computerized method of tailoring work instructions to perform on a part, comprises: providing at least one computer having memory with global work instructions relevant to a plurality of parts and to a plurality of work locations; receiving part identifier information and work location information and processing the part identifier and work location information at the computer; and then generating tailored work instructions from the computer responsive to the part identifier and work location information wherein the tailored work instructions are reviewed and performed on the part. A computerized method of dispositioning of parts, comprises providing at least one computer; receiving part identifier information for first and second part at the computer; determining a disposition of the first part then the second part, each disposition responsive to the part identifier information; determining whether the second part disposition requires adjustment to the first part disposition; and if necessary, modifying the first part disposition wherein the first and second parts are dispositioned according to the dispositions.
Patent NZ-520021-A (NZ)
Title: Passive integrated transponder (PIT) tag having unitary antenna core with coil portion and integrated circuit portion
Inventor: MEJIA EZEQUIEL
IPC: H01Q1/40
Filed: 2001-01-11
Abstract: A  passive integrated transponder (PIT) tag comprising an  integrated  circuit  (14) and a  unitary  core  (12)  is described.   The  unitary  core  comprises  a   coil-forming portion  (16)  proximate one end thereof and  an  integrated circuit  support  portion  (18) proximate  an  opposite  end thereof.  The  integrated  circuit support  portion  extends beneath and supports the integrated circuit